TXMD
TherapeuticsMD Inc
NASDAQ: TXMD · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.04
-3.32% today
Updated 2026-04-30
Market cap
$24.31M
P/E ratio
—
P/S ratio
8.04x
EPS (TTM)
$-0.06
Dividend yield
—
52W range
$1 – $3
Volume
0.0M
TherapeuticsMD Inc (TXMD) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.81M | $1.87M | $495364.00 | $54419.00 | $849765.00 | $467417.00 | $1.44M | $5.82M | $62.02M | $59.08M | $73.73M | $142.47M | $143.23M | $211.98M | $265.99M | $181.61M | $169.47M | $90.46M | $43.31M | $38.82M |
| Cash & equivalents | $902257.00 | $985729.00 | $408634.00 | $54419.00 | $42066.00 | $1497.00 | $126421.00 | $1.55M | $54.19M | $51.36M | $64.71M | $131.53M | $127.14M | $161.61M | $160.83M | $80.49M | $64.91M | $38.07M | $4.33M | $5.06M |
| Current assets | $1.06M | $1.11M | $495364.00 | $54419.00 | $69872.00 | $7085.00 | $1.24M | $4.53M | $59.40M | $56.24M | $70.68M | $139.41M | $139.55M | $186.78M | $208.42M | $128.40M | $119.47M | $55.35M | $11.80M | $9.93M |
| Total liabilities | $493182.00 | $179826.00 | $77826.00 | $35722.00 | $1.16M | $1.37M | $3.15M | $7.25M | $7.32M | $10.69M | $10.67M | $14.98M | $13.32M | $114.46M | $256.78M | $305.61M | $263.09M | $55.31M | $14.02M | $11.45M |
| Current liabilities | $434354.00 | $115131.00 | $77826.00 | $35722.00 | $1.16M | $1.37M | $3.15M | $3.51M | $7.32M | $10.69M | $10.67M | $14.98M | $13.32M | $41.08M | $53.00M | $59.24M | $252.89M | $46.84M | $6.85M | $5.17M |
| Long-term debt | — | — | — | — | — | — | $0.00 | $3.59M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $73.38M | $194.63M | $237.70M | — | — | — | — |
| Shareholder equity | $1.31M | $1.69M | $417538.00 | $18697.00 | $-311052.00 | $-907552.00 | $-1.71M | $-1.43M | $54.70M | $48.39M | $63.06M | $127.49M | $129.91M | $97.52M | $9.20M | $-124.00M | $-93.62M | $35.14M | $29.29M | $27.37M |
| Retained earnings | $115102.00 | $196963.00 | $23653.00 | $-578618.00 | $-1.89M | $-2.59M | $-16.99M | $-52.11M | $-80.53M | $-134.75M | $-219.83M | $-309.70M | $-386.66M | $-519.28M | $-695.42M | $-878.95M | $-1.05B | $-939.36M | $-949.64M | $-951.82M |
| Accounts receivable | $157959.00 | $124900.00 | $86730.00 | — | $10568.00 | $5588.00 | $26720.00 | $606641.00 | $1.69M | $2.40M | $3.05M | $4.50M | $4.33M | $11.06M | $24.40M | $32.38M | $36.18M | — | $3.09M | $3.56M |
| Inventory | — | — | — | — | — | — | $588073.00 | $1.62M | $1.04M | $1.18M | $690153.00 | $1.08M | $1.49M | $3.27M | $11.86M | $7.99M | $7.62M | — | — | — |
| Goodwill | — | — | — | — | — | $288443.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |